BioCorRx Shares Financial Results for Q2 2017

BioCorRx released their financial report for the second quarter of 2017 and provided a business update to shareholders.

BioVie Obtains FDA Approval For Clinical Trial

BioVie (OTCQB:BIVI) received clearance from the US Food and Drug Administration (FDA) to begin a Phase 2a clinical trial for...